1. Apricus Biosciences Announces Appointment of Wendell Wierenga, Ph.D., to Board of Directors

    Apricus Biosciences Announces Appointment of Wendell Wierenga, Ph.D., to Board of Directors

    SAN DIEGO, March 10, Mar 10, 2014 (GLOBE NEWSWIRE via COMTEX) -- Apricus Biosciences, Inc. (NASDAQ:APRI), today announced the appointment of Wendell Wierenga, Ph.D., to the Company's Board of Directors. Dr. Wierenga brings decades of experience heading research and development programs that led to the marketing approval of over 15 medicines and has participated in the filing of over 70 Investigational New Drug (IND) disclosures. His appointment is effective immediately.

     

    Read Full Article

    Login to comment.

  1. Categories

    1. BoardProspects Features:

      BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Member Report, Partner Publications, Question of The Week, Sponsored Content
  2. Topics Mentioned